Untreated Depression May Increase Later Dementia Risk
FRIDAY, Oct. 28, 2022 (HealthDay News) -- Symptomatic depression is associated with a 51 percent increased risk of dementia, according to a study published online Sept. 3 in Biological Psychiatry.
Liu Yang, M.D., from Fudan University in Shanghai, and colleagues examined associations between courses of depression, depression treatment, and the risk of incident dementia. Analysis included 354,313 participants (ages 50 to 70 years) in the U.K. Biobank (2006 to 2010) who were followed until 2020.
The researchers found that depression was associated with a 51 percent higher risk of dementia. The increasing, chronically high, and chronically low depression courses were associated with increased dementia risk, but no association was seen for decreasing depression course. Receiving depression treatments led to a reduction in risk of dementia versus not receiving treatment (hazard ratio, 0.7). Treatment for those with increasing and chronically low symptoms of depression was associated with a 42 and 29 percent lower risk of dementia, respectively, while the reduction effect of treatment for chronically high symptoms was insignificant.
"This indicates that timely treatment of depression is needed among those with late-life depression," a coauthor said in a statement. "Providing depression treatment for those with late-life depression might not only remit affective symptoms but also postpone the onset of dementia."
Abstract/Full Text (subscription or payment may be required)
Related Posts
TikTok Videos on Abortion Pills Are Largely Accurate: Study
FRIDAY, Feb. 3, 2023 (HealthDay News) -- While you can't trust everything you...
Number of Births, Fertility Rate Increased in 2021
TUESDAY, May 24, 2022 (HealthDay News) -- In 2021, there was an increase in the...
AHA News: The COVID-19 Emergency Is Over, But the Need For Awareness Remains, Experts Say
THURSDAY, May 25, 2023 (American Heart Association News) -- The official word on...
Unos nuevos datos confirman que el refuerzo actualizado de Pfizer se dirige a las variantes ómicron
VIERNES, 14 de octubre de 2022 (HealthDay News) -- Los datos de un nuevo ensayo...